Suppr超能文献

MICA在高级别浸润性可手术乳腺癌中的上调。

Upregulation of MICA on high-grade invasive operable breast carcinoma.

作者信息

Madjd Zahra, Spendlove Ian, Moss Robert, Bevin Shaun, Pinder Sarah E, Watson Nicholas F S, Ellis Ian, Durrant Lindy G

机构信息

Academic Department of Clinical Oncology, Institute of Infections, Immunity and Inflammation, University of Nottingham, City Hospital, Nottingham, NG5 1PB, United Kingdom.

出版信息

Cancer Immun. 2007 Oct 22;7:17.

Abstract

The MHC class I chain-related gene A (MICA) is frequently expressed on the surface of intestinal epithelium and by many epithelial tumours. MICA is a stress-induced antigen which was identified as an activator of natural killer cells via interaction with the NKG2D receptor. We have raised a rabbit polyclonal antibody against a synthetic peptide that recognises denatured MICA on both Western blots and in formalin-fixed paraffin-embedded sections. In the present study this antibody was used to undertake a definitive study of 530 breast cancer cases with mean follow up of 7 years to determine the prognostic significance of MICA expression. To detect any association between MICA expression and NK infiltration, whole sections of 50 tumours were also analysed for CD56 staining. Univariate analysis showed significant relationships between MICA expression and histological grade (P = 0.006), lymph node stage (P = 0.013), Nottingham Prognostic Index (NPI, P = 0.002), the presence of vascular invasion (P = 0.045) and tumour type (P = 0.023). Upregulation of MICA was more often found in histological grade 3, poor prognosis (NPI >5.4) tumours. Association of high MICA expression with NK cell infiltration was not demonstrated, as very few NK cells were present in whole breast sections. Our results suggest that induced expression of MICA may be an indicator of poor prognosis in breast carcinoma and is indicative of a tumour environment that has undergone stresses such as apoptosis, necrosis, or hypoxia.

摘要

MHC I类链相关基因A(MICA)常在肠道上皮表面以及许多上皮肿瘤中表达。MICA是一种应激诱导抗原,通过与NKG2D受体相互作用被鉴定为自然杀伤细胞的激活剂。我们制备了一种针对合成肽的兔多克隆抗体,该抗体在蛋白质免疫印迹法和福尔马林固定石蜡包埋切片中均可识别变性的MICA。在本研究中,使用该抗体对530例乳腺癌病例进行了一项确定性研究,平均随访7年,以确定MICA表达的预后意义。为检测MICA表达与自然杀伤细胞浸润之间的任何关联,还对50个肿瘤的全切片进行了CD56染色分析。单因素分析显示,MICA表达与组织学分级(P = 0.006)、淋巴结分期(P = 0.013)、诺丁汉预后指数(NPI,P = 0.002)、血管侵犯情况(P = 0.045)和肿瘤类型(P = 0.023)之间存在显著相关性。MICA上调更常见于组织学3级、预后不良(NPI>5.4)的肿瘤。由于全乳腺切片中自然杀伤细胞极少,未证实MICA高表达与自然杀伤细胞浸润有关。我们的结果表明,MICA的诱导表达可能是乳腺癌预后不良的一个指标,并且表明肿瘤环境经历了诸如凋亡、坏死或缺氧等应激。

相似文献

2
CD56+ immune cell infiltration and MICA are decreased in breast lobules with fibrocystic changes.
Breast Cancer Res Treat. 2018 Feb;167(3):649-658. doi: 10.1007/s10549-017-4558-0. Epub 2017 Nov 1.
3
6
Granulin-epithelin precursor renders hepatocellular carcinoma cells resistant to natural killer cytotoxicity.
Cancer Immunol Res. 2014 Dec;2(12):1209-19. doi: 10.1158/2326-6066.CIR-14-0096. Epub 2014 Oct 14.
8
CD24 targeting bi-specific antibody that simultaneously stimulates NKG2D enhances the efficacy of cancer immunotherapy.
J Cancer Res Clin Oncol. 2019 May;145(5):1179-1190. doi: 10.1007/s00432-019-02865-8. Epub 2019 Feb 18.

引用本文的文献

4
Soluble NKG2DLs Are Elevated in Breast Cancer Patients and Associate with Disease Outcome.
Int J Mol Sci. 2024 Apr 8;25(7):4126. doi: 10.3390/ijms25074126.
5
The Role and Regulation of the NKG2D/NKG2D Ligand System in Cancer.
Biology (Basel). 2023 Aug 2;12(8):1079. doi: 10.3390/biology12081079.
7
Immunotherapeutic targeting of activating natural killer cell receptors and their ligands in cancer.
Clin Exp Immunol. 2022 Jul 22;209(1):22-32. doi: 10.1093/cei/uxac028.

本文引用的文献

1
Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990-1999.
Eur J Cancer. 2007 Jul;43(10):1548-55. doi: 10.1016/j.ejca.2007.01.016. Epub 2007 Feb 26.
2
Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance.
Eur J Cancer. 2006 Dec;42(18):3149-56. doi: 10.1016/j.ejca.2006.08.015. Epub 2006 Oct 19.
3
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
6
Total loss of MHC class I is an independent indicator of good prognosis in breast cancer.
Int J Cancer. 2005 Nov 1;117(2):248-55. doi: 10.1002/ijc.21163.
7
Nomenclature for factors of the HLA system, 2004.
Tissue Antigens. 2005 Apr;65(4):301-69. doi: 10.1111/j.1399-0039.2005.00379.x.
8
Global cancer statistics, 2002.
CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108. doi: 10.3322/canjclin.55.2.74.
10
Human MHC class I chain related (MIC) genes: their biological function and relevance to disease and transplantation.
Eur J Immunogenet. 2004 Jun;31(3):105-14. doi: 10.1111/j.1365-2370.2004.00457.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验